
Nicox and Kowa sign agreement for exclusive rights to glaucoma treatment NCX 470
Nicox and Kowa have entered into an agreement regarding NCX 470, Nicox’s nitric oxide (NO)-donating bimatoprost eye drop, for the lowering of intraocular pressure (IOP) in patients with glaucoma or ocular hypertension. According to the agreement, Kowa …